SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-13-005450
Filing Date
2013-11-12
Accepted
2013-11-12 07:45:44
Documents
3
Period of Report
2013-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS, INC. 8-K a50748730.htm 8-K 22629
2 EXHIBIT 99.1 a50748730_ex991.htm EX-99.1 55778
3 EXHIBIT 99.2 a50748730_ex992.htm EX-99.2 4622
  Complete submission text file 0001157523-13-005450.txt   84274
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36172 | Film No.: 131206988
SIC: 2836 Biological Products, (No Diagnostic Substances)